Literature DB >> 23095852

Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment.

Michael Wittie1, Lorene M Nelson, Sharon Usher, Kevin Ward, Michael Benatar.   

Abstract

BACKGROUND: With the establishment of a national amyotrophic lateral sclerosis (ALS) registry in the United States, methods are needed to ascertain the completeness of case ascertainment, especially in view of the proposal to rely largely on existing data sources.
METHODS: Data about ALS patients residing in the 5-county metropolitan Atlanta area (within the State of Georgia) from 2001 to 2005 were categorized according to their source--ALS Association, clinical (Emory Healthcare, community neurologist, Veterans Health Administration, Veterans Benefits Administration), Medicare and death certificates. ALS diagnoses were verified using chart review. Capture-recapture analyses were carried out using log-linear modeling, stratified by age and race.
RESULTS: The final model (based on 798 cases), which included the 4 main sources and 3 two-way interaction terms, yielded an estimated total population of 880 (95% CI 816-965), indicating that the combination of case-finding methods identified about 90.7% of cases. The estimated 5-year period prevalence is 38.5/100,000 (95% CI 35.66-42.19).
CONCLUSION: This study highlights gaps in data based on existing data sources and illustrates a method for combining data from multiple sources to help facilitate the successful establishment of a US national ALS registry.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23095852     DOI: 10.1159/000342156

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  6 in total

Review 1.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 2.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

3.  Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia.

Authors:  Heather Jordan; Lindsay Rechtman; Laurie Wagner; Wendy E Kaye
Journal:  Muscle Nerve       Date:  2015-02-11       Impact factor: 3.217

Review 4.  Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update.

Authors:  Roohi Mohi-Ud-Din; Reyaz Hassan Mir; Abdul Jalil Shah; Saba Sabreen; Taha Umair Wani; Mubashir Hussain Masoodi; Esra Küpeli Akkol; Zulfiqar Ali Bhat; Haroon Khan
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

5.  A new method for estimating under-recruitment of a patient registry: a case study with the Ohio Registry of Amyotrophic Lateral Sclerosis.

Authors:  Meifang Li; Xun Shi; Jiang Gui; Chao Song; Angeline S Andrew; Erik P Pioro; Elijah W Stommel; Maeve Tischbein; Walter G Bradley
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

6.  Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia.

Authors:  Hatice Uenal; Angela Rosenbohm; Johannes Kufeldt; Patrick Weydt; Katharina Goder; Albert Ludolph; Dietrich Rothenbacher; Gabriele Nagel
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.